User login
- /content/car-t-dlbcl-liso-cel-has-remarkable-efficacy-cohort
- /hematologynews/article/169042/aggressive-lymphomas/car-t-dlbcl-liso-cel-has-remarkable-efficacy
- /jcso/article/169042/aggressive-lymphomas/car-t-dlbcl-liso-cel-has-remarkable-efficacy-cohort
- /oncologypractice/article/169042/aggressive-lymphomas/car-t-dlbcl-liso-cel-has-remarkable-efficacy
- /hematologynews/nhlhub/article/169042/aggressive-lymphomas/car-t-dlbcl-liso-cel-has-remarkable
- /hematology-oncology/article/169042/aggressive-lymphomas/car-t-dlbcl-liso-cel-has-remarkable-efficacy
- /b-cell-lymphoma-icymi/article/169042/aggressive-lymphomas/car-t-dlbcl-liso-cel-has-remarkable